Get started
Alnylam Pharmaceuticals, Inc. 1.0% 15-SEP-2027Alnylam Pharmaceuticals, Inc. 1.0% 15-SEP-2027Alnylam Pharmaceuticals, Inc. 1.0% 15-SEP-2027

Alnylam Pharmaceuticals, Inc. 1.0% 15-SEP-2027

No trades
See on Supercharts
Overview
Analysis News

ALNY5653584 chart


Full chart

Key terms


Outstanding amount
‪1.03 B‬ USD
Face value
1,000.00 USD
Minimum denomination
1,000.00 USD
Coupon
1.00% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
−2.10%
Maturity date
Sep 15, 2027
Term to maturity
2 years

About Alnylam Pharmaceuticals, Inc. 1.0% 15-SEP-2027


Issuer
Alnylam Pharmaceuticals, Inc.
Sector
Health Technology
Home page
alnylam.com
Issue date
Sep 15, 2023
FIGI
BBG019LVCV78
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

ALNY5653584 analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

ALNY5653584 news